BURIONI, ROBERTO
 Distribuzione geografica
Continente #
EU - Europa 4.436
AS - Asia 3.597
NA - Nord America 3.410
SA - Sud America 976
Continente sconosciuto - Info sul continente non disponibili 174
AF - Africa 82
OC - Oceania 11
Totale 12.686
Nazione #
US - Stati Uniti d'America 3.242
RU - Federazione Russa 2.345
SG - Singapore 1.324
CN - Cina 1.145
BR - Brasile 779
IT - Italia 703
SE - Svezia 637
HK - Hong Kong 437
VN - Vietnam 353
FR - Francia 198
DE - Germania 142
GB - Regno Unito 101
CA - Canada 86
AR - Argentina 82
FI - Finlandia 73
IN - India 68
BD - Bangladesh 62
NL - Olanda 62
PL - Polonia 40
EC - Ecuador 37
MX - Messico 37
ZA - Sudafrica 33
ID - Indonesia 29
ES - Italia 28
AT - Austria 27
CO - Colombia 27
JP - Giappone 26
IQ - Iraq 23
IE - Irlanda 22
TR - Turchia 17
SA - Arabia Saudita 15
PY - Paraguay 14
UZ - Uzbekistan 14
CL - Cile 11
NP - Nepal 11
RO - Romania 11
UA - Ucraina 11
JM - Giamaica 10
PH - Filippine 10
PK - Pakistan 10
LT - Lituania 9
MA - Marocco 9
TN - Tunisia 9
VE - Venezuela 9
AU - Australia 8
EG - Egitto 8
MY - Malesia 8
PE - Perù 8
HN - Honduras 7
KE - Kenya 7
UY - Uruguay 7
CR - Costa Rica 6
IR - Iran 6
TT - Trinidad e Tobago 6
AE - Emirati Arabi Uniti 5
DO - Repubblica Dominicana 5
DZ - Algeria 5
BH - Bahrain 4
CZ - Repubblica Ceca 4
AZ - Azerbaigian 3
GA - Gabon 3
JO - Giordania 3
KZ - Kazakistan 3
NI - Nicaragua 3
NZ - Nuova Zelanda 3
TH - Thailandia 3
TW - Taiwan 3
BE - Belgio 2
BG - Bulgaria 2
BO - Bolivia 2
BS - Bahamas 2
BY - Bielorussia 2
DK - Danimarca 2
GD - Grenada 2
GE - Georgia 2
IL - Israele 2
IS - Islanda 2
KW - Kuwait 2
MD - Moldavia 2
MU - Mauritius 2
RS - Serbia 2
SI - Slovenia 2
AF - Afghanistan, Repubblica islamica di 1
AL - Albania 1
BA - Bosnia-Erzegovina 1
CH - Svizzera 1
CI - Costa d'Avorio 1
EU - Europa 1
GP - Guadalupe 1
GR - Grecia 1
HR - Croazia 1
KG - Kirghizistan 1
KR - Corea 1
LA - Repubblica Popolare Democratica del Laos 1
LB - Libano 1
LC - Santa Lucia 1
ME - Montenegro 1
ML - Mali 1
NG - Nigeria 1
OM - Oman 1
Totale 12.504
Città #
Dallas 655
Singapore 538
Moscow 488
Hong Kong 434
Ashburn 410
San Jose 334
Shanghai 240
Council Bluffs 197
Hefei 180
Princeton 171
Lawrence 168
Lauterbourg 155
Milan 147
Beijing 144
Ho Chi Minh City 131
New York 118
Los Angeles 74
São Paulo 72
Hanoi 68
Santa Clara 56
Helsinki 55
Rome 42
Orem 41
Warsaw 34
Bologna 33
Munich 33
London 32
Chennai 29
Nuremberg 28
Montreal 27
Rio de Janeiro 25
Chicago 24
Bari 23
Johannesburg 23
Dublin 22
Stockholm 22
Toronto 22
Ancona 21
Atlanta 21
Seattle 21
Boardman 20
Tokyo 20
Brasília 19
Guangzhou 18
Poplar 18
Boston 17
Brooklyn 17
Turin 17
Amsterdam 16
Mexico City 16
Biên Hòa 15
Brescia 15
Denver 15
Phoenix 15
Quito 15
Belo Horizonte 14
Da Nang 14
Shenzhen 13
Falkenstein 12
Haiphong 12
Hangzhou 12
Houston 12
Naples 12
Pune 12
Tashkent 12
Tianjin 12
Turku 12
Frankfurt am Main 11
Manchester 11
San Francisco 11
Washington 11
Catania 10
Curitiba 10
Guayaquil 10
Vienna 10
Ankara 9
Guarulhos 9
Ninh Bình 9
Santo André 9
Sorocaba 9
Florence 8
Jeddah 8
Manaus 8
Marino 8
Porto Alegre 8
Salvador 8
Verona 8
Asunción 7
Bogotá 7
Calgary 7
Columbus 7
Milwaukee 7
Nairobi 7
Trento 7
Campinas 6
Cape Town 6
Changsha 6
City of London 6
Contagem 6
Duhok 6
Totale 6.030
Nome #
Salute : Le frontiere della medicina : Volumi dedicati alla Salute a cura di Roberto Burioni 277
A Human Stem Cell-Derived Neurosensory–Epithelial Circuitry on a Chip to Model Herpes Simplex Virus Reactivation 230
Virus, la grande sfida : dal coronavirus alla peste : come la scienza può salvare l'umanità / Roberto Burioni ; con la collaborazione di Pier Luigi Lopalco 226
Evaluation of respiratory virus transmissibility and resilience from fomites: the case of 11 SARS-CoV-2 clinical isolates 199
Trends of Antimicrobial Susceptibility of Neisseria gonorrhoeae Isolates between 2012 and 2023: Results from an Open Italian Cohort 135
A Biologically-validated HCV E1E2 Heterodimer Structural Model 134
Interferon-β 1a inhibits SARS-CoV-2 in vitro when administered after virus infection 132
Cloning of the first human anti-JCPyV/VP1 neutralizing monoclonal antibody: Epitope definition and implications in risk stratification of patients under natalizumab therapy 130
A phage display vector optimized for the generation of human antibody combinatorial libraries and the molecular cloning of monoclonal antibody fragments 130
A Human Monoclonal Antibody with Neutralizing Activity against Highly Divergent Influenza Subtypes 129
Combined Prophylactic and Therapeutic Use Maximizes Hydroxychloroquine Anti-SARS-CoV-2 Effects in vitro 129
Cell-to-cell spread-blocking activity is extremely limited in the sera of HSV-1 and HSV-2 infected subjects 127
A non-VH1-69 heterosubtypic neutralizing human monoclonal antibody protects mice against H1N1 and H5N1 viruses 120
A potential role for monoclonal antibodies in prophylactic and therapeutic treatment of influenza 114
ANTI-HIV-1 RESPONSE ELICITED IN RABBITS BY ANTI-IDIOTYPE MONOCLONAL ANTIBODIES MIMICKING THE CD4-BINDING SITE ON GP120 111
Bacteriophages and Their Immunological Applications against Infectious Threats 110
A vector for the expression of recombinant monoclonal Fab fragments in bacteria 108
Single spike mutation differentiating XBB.1 and XBB.1.5 enhances SARS-CoV-2 cell-to-cell transmission and facilitates serum-mediated enhancement 107
Adoptive T-cell therapy in the treatment of viral and opportunistic fungal infections 105
Differential composition of vaginal microbiome, but not of seminal microbiome, is associated with successful intrauterine insemination in couples with idiopathic infertility: A prospective observational study 105
Novel therapeutic investigational strategies to treat severe and disseminated HSV infections suggested by a deeper understanding of in vitro virus entry processes 105
Rectal Lymphogranuloma venereum among Men who Have Sex with Men: 7 versus 21 Days Doxycycline Effectiveness 102
Adaptive immunity against gut microbiota enhances apoE-mediated immune regulation and reduces atherosclerosis and western-diet-related inflammation 101
Acute respiratory distress in a neutropenic febrile patient after hematopoietic cell transplantation 101
A closer look at prion strains: Characterization and important implications 101
Broadly neutralizing anti-influenza human monoclonal antibodies and their possible role in predictive medicine 101
IN VIVO PROTECTION CONFERRED BY HUMAN MONOCLONAL ANTIBODY DIRECTED AGAINST HSV-1 AND 2 101
Neutralization Interfering Antibodies: a "Novel" Mechanism of Humoral Immune Mutiny and Viral Evasion? 99
Detection of low-level HCV variants in DAA treated patients: comparison amongst three different NGS data analysis protocols 99
A recombinant human Fab inhibits helicase activity of HCVNS3 and negative strand RNA synthesis 97
Heterosubtypic protection conferred by the human monoclonal antibody PN-SIA28 against influenza A virus lethal infections in mice 96
A novel expression vector for production of epitope-tagged recombinant Fab-fragment in bacteria 96
Anti-HIV-1 response elicited in rabbits by anti-idiotype monoclonal antibodies mimicking the CD4-binding site 95
A recombinant human Fab inhibits activity of HCVNS3 and negative strand RNA synthesis 94
Chimeric antigen receptor (CAR)-engineered T cells redirected against hepatitis C virus (HCV) E2 glycoprotein 94
Major sports events and the transmission of sars-cov-2: Analysis of seven case-studies in europe 94
Entry inhibition of HSV-1 and -2 protects mice from viral lethal challenge 93
A novel efflux system in inducibly erythromycin-resistant strains of Streptococcus pyogenes 90
A recombinant human Fab inhibits helicase activity of HCVNS3 and negative strand RNA synthesis 89
"Freezing" parasites in pre-Himalayan region, Himachal Pradesh: Experience with mini-FLOTAC 88
SARS-CoV-2 before and after Omicron: two different viruses and two different diseases? 87
63. Vaccini Antivirali 87
A NEW PLASMID CLONING VECTOR FOR DIRECT-DETECTION OF RECOMBINANT CLONES, BASED ON INACTIVATION OF A BACTERIAL ACID PHOSPHATASE-ENCODING GENE 87
Weak correlation between antibody titers and neutralizing activity in sera from SARS-CoV-2 infected subjects 87
Match point. Come la scienza sta sconfiggendo il cancro 86
Characterization of two human monoclonal anti-E2/HCV antibodies for potential application in prevention and treatment of HCV infection 86
Antigen-driven evolution of B lymphocytes in coronary atherosclerotic plaques 86
Structural basis for a human broadly neutralizing influenza A hemagglutinin stem-specific antibody including H17/18 subtypes 85
Answer to February 2019 Photo Quiz: Neurological Symptoms in a 74-Year-Old Diabetic Woman Admitted to the Emergency Room 85
Global and local envelope protein dynamics of hepatitis C virus determine broad antibody sensitivity 85
Influenza B-cells protective epitope characterization: a passkey for the rational design of new broad-range anti-influenza vaccines 84
36. Meccanismi difensivi dell'ospite alle infezioni virali 83
A new subtraction technique for molecular cloning of rare antiviral antibody specificities from phage display libraries 82
66. Vaccini antivirali 82
Epitope mapping by epitope excision, hydrogen/deuterium exchange, and peptide-panning techniques combined with in silico analysis 81
Characterization of epitopes recognized by monoclonal antibodies: experimental approaches supported by freely accessible bioinformatic tools 79
Role and potential therapeutic use of antibodies against herpetic infections 79
Assessing the human immune response to SARS-CoV-2 variants 79
Molecular characterization of the human neutralizing response against hepatitis C virus and its role in the prediction of the infection outcome 78
HCV E2 core structures and mAbs: something is still missing 77
39 Meccanismi difensivi dell'ospite alle infezioni virali 72
Molecular diagnosis of sepsis in neutropenic patients with haematological malignancies 72
Virus-induced preferential antibody gene-usage and its importance in humoral autoimmunity 71
Microbiological Diagnosis of Sepsis: The Confounding Effects of a “Gold Standard” 71
HUMAN MONOCLONAL ANTIBODY ENDOWED WITH ANTI-HSV-1 AND -2 ACTIVITY STRONGLY INHIBITS VIRUS REPLICATION 69
Monoclonal antibodies isolated from human B cells neutralize a broad range of H1 subtype influenza A viruses including swine-origin Influenza virus (S-OIV) 68
Anti-HCV monoclonal antibody as a medicament for the therapeutic treatment and prevention of HCV infections 67
Has SARS-CoV-2 reached peak fitness? 66
Method for the preparation of new oligoclonal antibodies 65
Anti-idiotype monoclonal antibodies as mimotopes of the HIV gp120 antigen 64
Phage display-based strategies for cloning and optimization of monoclonal antibodies directed against human pathogens 64
Early molecular diagnosis of aspergillosis in a patient with acute myeloid leukaemia 63
Phage display for the production of human monoclonal antibodies against human pathogens 63
Risks of "blind" automated identification systems in medical microbiology 62
Humoral immune response against hepatitis C virus 62
Cross-reactive pseudovirus-neutralizing anti-envelope antibodies coexist with antibodies devoid of such activity in persistent hepatitis C virus infection 61
Human monoclonal recombinant antibody against NS3 HCV protein and methods therefor 61
Monoclonal antibodies having homosubtype cross-neutralization properties against influenza A viruses subtype H1 61
Blocking immunodominant epitopes by competitive deselection. 61
Il vaccino non è un'opinione. Le vaccinazioni spiegate a chi proprio non le vuole capire 61
Photo quiz: Neurological symptoms in a 74-year-old diabetic woman admitted to the emergency room 61
Phage Display Technology 60
Synergy evaluation of anti-Herpes Simplex Virus type 1 and 2 compounds acting on different steps of virus life cycle 60
Correspondence: Italy's policy shift on immunization 60
Monoclonal antibodies as a medicament for the therapeutic and/or prophylactic treatment of swine-origin influenza A (H1N1) virus (S-OIV) infections 59
Comparative Evaluation of the Bruker Biotyper and Vitek MS Matrix-Assisted Laser Desorption Ionization–Time Of Flight (MALDI-TOF) Mass Spectrometry Systems for Identification of Yeasts of Medical Importance 59
Direct sequencing of Scedosporium apiospermum DNA in the diagnosis of a case of keratitis 59
Intracytoplasmic stable expression of IgG1 antibody targeting NS3 helicase inhibits replication of highly efficient hepatitis C Virus 2a clone 59
CLONING AND CHARACTERIZATION OF HUMAN RECOMBINANT ANTIBODY FAB FRAGMENTS SPECIFIC FOR TYPE-1 AND TYPE-2 HERPES-SIMPLEX VIRUS 58
Definition of biological activity and quantitation of different families of human anti-HCV/E2 antibodies by generation of human recombinant anti-E2 monoclonal Fab by phage display combinatorial repertoire library 58
Possible future monoclonal antibody (mAb)-based therapy against arbovirus infections 58
Enteric microbiome markers as early predictors of clinical outcome in allogeneic hematopoietic stem cell transplant (allo-HSCT): results of a prospective study in adult patients 58
Quantitation of Bacillus clausii in biological samples by real-time polymerase chain reaction 58
Evaluation of a synergistic interactions of anti-E2/HCV monoclonal antibodies 57
How Long Can Stool Samples Be Fixed for an Accurate Diagnosis of Soil-Transmitted Helminth Infection Using Mini-FLOTAC? 56
Molecular Cloning of a Human Monoclonal Antibody neutralizing a broad range of H1 subtype influenza virus including swine-origin influenza virus (S-OIV) 56
Hepatitis C virus (HCV)-driven stimulation of subfamily-restricted natural IgM antibodies in mixed cryoglobulinemia 56
Inhibition of HCV-NS3 helicase activity and negative strand RNA syntesis by intracelllular expression of a recombinant human anti-NS3 Fab 55
Nonneutralizing human antibody fragments against hepatitis C virus E2 glycoprotein modulate neutralization of binding activity of human recombinant Fabs 54
Dissection of the IgA1 local response by construction of isotype-specific combinatorial libraries displayed on the surface of phage from gastro-jejunal biopsies. 54
Totale 8.918
Categoria #
all - tutte 80.764
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 80.764


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022142 0 0 7 41 6 3 17 14 6 27 7 14
2022/20231.104 387 281 95 11 11 135 48 56 55 3 14 8
2023/2024530 24 38 79 62 29 100 11 43 4 38 19 83
2024/20252.405 292 34 45 131 72 225 354 217 430 273 154 178
2025/20267.775 608 629 805 1.149 526 254 640 532 2.051 332 121 128
2026/2027585 283 302 0 0 0 0 0 0 0 0 0 0
Totale 12.686